Robert Weinstein
Concepts (335)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glucocorticoids | 12 | 2017 | 234 | 3.480 |
Why?
| Bone and Bones | 20 | 2020 | 516 | 2.370 |
Why?
| Osteocytes | 15 | 2015 | 220 | 2.290 |
Why?
| Osteoblasts | 27 | 2018 | 514 | 1.970 |
Why?
| Osteoporosis | 9 | 2018 | 164 | 1.820 |
Why?
| Osteonecrosis | 4 | 2017 | 36 | 1.720 |
Why?
| Apoptosis | 20 | 2017 | 1300 | 1.640 |
Why?
| Diphosphonates | 8 | 2013 | 96 | 1.620 |
Why?
| Osteoclasts | 19 | 2017 | 469 | 1.490 |
Why?
| Bone Density | 23 | 2017 | 416 | 1.310 |
Why?
| Bone Density Conservation Agents | 6 | 2013 | 83 | 1.240 |
Why?
| Bone Remodeling | 11 | 2017 | 177 | 1.070 |
Why?
| Osteogenesis | 12 | 2018 | 377 | 0.910 |
Why?
| Alendronate | 4 | 2011 | 20 | 0.850 |
Why?
| Prednisolone | 4 | 2011 | 57 | 0.830 |
Why?
| Hypophosphatemia | 1 | 2019 | 7 | 0.730 |
Why?
| Aging | 10 | 2017 | 784 | 0.700 |
Why?
| Parathyroid Hormone | 7 | 2010 | 196 | 0.690 |
Why?
| Femur Head Necrosis | 1 | 2017 | 17 | 0.630 |
Why?
| Femur Head | 1 | 2017 | 27 | 0.620 |
Why?
| Animals | 46 | 2018 | 14385 | 0.610 |
Why?
| Mice | 36 | 2017 | 6413 | 0.590 |
Why?
| Estrogen Receptor alpha | 5 | 2015 | 95 | 0.520 |
Why?
| RANK Ligand | 9 | 2014 | 183 | 0.480 |
Why?
| Bone Resorption | 9 | 2014 | 326 | 0.470 |
Why?
| Mice, Inbred C57BL | 17 | 2018 | 1999 | 0.430 |
Why?
| Osteoprotegerin | 2 | 2011 | 57 | 0.430 |
Why?
| Femur | 8 | 2016 | 144 | 0.370 |
Why?
| Oxidative Stress | 8 | 2013 | 958 | 0.360 |
Why?
| Imidazoles | 1 | 2010 | 142 | 0.350 |
Why?
| Neovascularization, Physiologic | 1 | 2009 | 72 | 0.350 |
Why?
| Wnt Signaling Pathway | 4 | 2016 | 94 | 0.350 |
Why?
| Water | 1 | 2009 | 102 | 0.350 |
Why?
| Spinal Fractures | 1 | 2009 | 41 | 0.340 |
Why?
| Forkhead Transcription Factors | 4 | 2014 | 118 | 0.330 |
Why?
| Bone Transplantation | 2 | 2013 | 55 | 0.330 |
Why?
| Bone Matrix | 3 | 2016 | 20 | 0.320 |
Why?
| Apicoectomy | 1 | 2007 | 1 | 0.310 |
Why?
| Periapical Diseases | 1 | 2007 | 2 | 0.310 |
Why?
| Guided Tissue Regeneration, Periodontal | 1 | 2007 | 4 | 0.310 |
Why?
| Transplantation, Heterologous | 1 | 2007 | 77 | 0.300 |
Why?
| Female | 34 | 2020 | 28441 | 0.300 |
Why?
| Dental Implantation, Endosseous | 2 | 2017 | 18 | 0.290 |
Why?
| Gene Deletion | 6 | 2015 | 293 | 0.290 |
Why?
| Orchiectomy | 3 | 2015 | 38 | 0.290 |
Why?
| Maxillary Diseases | 1 | 2006 | 3 | 0.280 |
Why?
| Jaw | 1 | 2006 | 4 | 0.280 |
Why?
| Cell Differentiation | 6 | 2013 | 720 | 0.270 |
Why?
| Calcium | 6 | 2014 | 432 | 0.270 |
Why?
| Dental Implants | 2 | 2017 | 31 | 0.260 |
Why?
| Mice, Transgenic | 10 | 2018 | 656 | 0.250 |
Why?
| Cells, Cultured | 10 | 2018 | 1737 | 0.250 |
Why?
| Humans | 27 | 2020 | 54284 | 0.250 |
Why?
| Selective Estrogen Receptor Modulators | 1 | 2003 | 25 | 0.230 |
Why?
| Male | 20 | 2020 | 27334 | 0.230 |
Why?
| Signal Transduction | 7 | 2015 | 1753 | 0.230 |
Why?
| Estrogen Replacement Therapy | 1 | 2003 | 41 | 0.230 |
Why?
| Spine | 6 | 2016 | 111 | 0.230 |
Why?
| Menopause | 1 | 2003 | 61 | 0.220 |
Why?
| Porosity | 3 | 2017 | 34 | 0.220 |
Why?
| Femoral Fractures | 2 | 2013 | 40 | 0.210 |
Why?
| Double-Blind Method | 3 | 2010 | 742 | 0.210 |
Why?
| Wnt Proteins | 4 | 2016 | 110 | 0.200 |
Why?
| Cell Line | 3 | 2011 | 1153 | 0.200 |
Why?
| Estrogens | 4 | 2012 | 244 | 0.200 |
Why?
| Periosteum | 2 | 2012 | 20 | 0.200 |
Why?
| Reactive Oxygen Species | 5 | 2014 | 491 | 0.190 |
Why?
| Middle Aged | 9 | 2020 | 13088 | 0.190 |
Why?
| Dexamethasone | 3 | 2011 | 435 | 0.190 |
Why?
| Osteogenesis Imperfecta | 1 | 2020 | 39 | 0.190 |
Why?
| Calcitriol | 1 | 2019 | 40 | 0.180 |
Why?
| Phosphates | 1 | 2019 | 51 | 0.180 |
Why?
| Enhancer Elements, Genetic | 2 | 2011 | 64 | 0.180 |
Why?
| Fibroblast Growth Factors | 1 | 2019 | 59 | 0.170 |
Why?
| Minerals | 2 | 2010 | 36 | 0.170 |
Why?
| Adult | 6 | 2020 | 14207 | 0.170 |
Why?
| Hyperparathyroidism | 2 | 2011 | 50 | 0.160 |
Why?
| Iron | 1 | 2019 | 158 | 0.160 |
Why?
| Immunoglobulin M | 1 | 2018 | 65 | 0.160 |
Why?
| Lumbar Vertebrae | 2 | 2013 | 105 | 0.160 |
Why?
| Single-Chain Antibodies | 1 | 2018 | 28 | 0.160 |
Why?
| Stem Cells | 4 | 2013 | 193 | 0.160 |
Why?
| Epitopes | 1 | 2018 | 89 | 0.160 |
Why?
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 2 | 2009 | 12 | 0.150 |
Why?
| Blotting, Western | 4 | 2016 | 683 | 0.150 |
Why?
| Biopsy | 3 | 2017 | 692 | 0.150 |
Why?
| Osseointegration | 1 | 2017 | 34 | 0.150 |
Why?
| Titanium | 1 | 2017 | 53 | 0.150 |
Why?
| Androgens | 2 | 2015 | 68 | 0.150 |
Why?
| Mice, Knockout | 6 | 2018 | 926 | 0.150 |
Why?
| Platelet-Rich Plasma | 1 | 2016 | 5 | 0.140 |
Why?
| Sinus Floor Augmentation | 1 | 2016 | 2 | 0.140 |
Why?
| Hydroxyapatites | 1 | 2016 | 7 | 0.140 |
Why?
| Maxilla | 1 | 2016 | 29 | 0.140 |
Why?
| Osteopetrosis | 1 | 2015 | 8 | 0.140 |
Why?
| rac GTP-Binding Proteins | 1 | 2015 | 6 | 0.140 |
Why?
| rac1 GTP-Binding Protein | 1 | 2015 | 12 | 0.140 |
Why?
| Autophagy | 2 | 2015 | 202 | 0.140 |
Why?
| Neuropeptides | 1 | 2015 | 48 | 0.140 |
Why?
| Apolipoproteins E | 1 | 2016 | 62 | 0.130 |
Why?
| Receptors, Androgen | 1 | 2015 | 49 | 0.130 |
Why?
| Bone Diseases, Metabolic | 1 | 2016 | 82 | 0.130 |
Why?
| X-Ray Microtomography | 4 | 2016 | 82 | 0.130 |
Why?
| Gene Expression Regulation | 3 | 2011 | 1062 | 0.130 |
Why?
| Diaphyses | 2 | 2013 | 4 | 0.130 |
Why?
| Aorta | 1 | 2016 | 177 | 0.130 |
Why?
| Calcium, Dietary | 1 | 2014 | 15 | 0.120 |
Why?
| Estradiol | 3 | 2013 | 219 | 0.120 |
Why?
| Catalase | 1 | 2014 | 74 | 0.120 |
Why?
| bcl-2 Homologous Antagonist-Killer Protein | 1 | 2014 | 22 | 0.120 |
Why?
| bcl-2-Associated X Protein | 1 | 2014 | 73 | 0.120 |
Why?
| Antibodies, Monoclonal, Humanized | 2 | 2013 | 240 | 0.120 |
Why?
| Tumor Necrosis Factor-alpha | 2 | 2016 | 434 | 0.120 |
Why?
| Hydrogen Peroxide | 1 | 2014 | 142 | 0.120 |
Why?
| Organ Size | 3 | 2015 | 237 | 0.120 |
Why?
| Tooth Socket | 1 | 2013 | 10 | 0.120 |
Why?
| Atherosclerosis | 1 | 2016 | 249 | 0.110 |
Why?
| Cell Count | 4 | 2016 | 181 | 0.110 |
Why?
| Gene Expression Regulation, Enzymologic | 1 | 2014 | 206 | 0.110 |
Why?
| Weight-Bearing | 1 | 2012 | 56 | 0.110 |
Why?
| Osteoporotic Fractures | 1 | 2012 | 11 | 0.110 |
Why?
| Biocompatible Materials | 2 | 2016 | 65 | 0.110 |
Why?
| Teriparatide | 1 | 2012 | 14 | 0.110 |
Why?
| Cell Proliferation | 5 | 2018 | 1096 | 0.110 |
Why?
| Cattle | 2 | 2016 | 224 | 0.110 |
Why?
| Cell Nucleus | 1 | 2013 | 203 | 0.110 |
Why?
| Bone Demineralization, Pathologic | 1 | 2011 | 5 | 0.110 |
Why?
| Risk Factors | 3 | 2013 | 3935 | 0.110 |
Why?
| Drug Monitoring | 1 | 2012 | 85 | 0.100 |
Why?
| Lactation | 1 | 2011 | 61 | 0.100 |
Why?
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2011 | 21 | 0.100 |
Why?
| Transcription Factors | 4 | 2013 | 622 | 0.100 |
Why?
| Prednisone | 1 | 2011 | 111 | 0.100 |
Why?
| Radiography | 4 | 2013 | 524 | 0.100 |
Why?
| Vitamin D | 1 | 2011 | 101 | 0.100 |
Why?
| Advisory Committees | 1 | 2010 | 66 | 0.090 |
Why?
| Anti-Inflammatory Agents | 1 | 2011 | 175 | 0.090 |
Why?
| Fractures, Bone | 1 | 2011 | 119 | 0.090 |
Why?
| Aged | 5 | 2016 | 10054 | 0.090 |
Why?
| Bone Diseases | 1 | 2011 | 109 | 0.090 |
Why?
| Research | 1 | 2010 | 110 | 0.090 |
Why?
| Treatment Outcome | 3 | 2013 | 5604 | 0.090 |
Why?
| Interleukin-6 | 2 | 2016 | 315 | 0.090 |
Why?
| Drug Administration Schedule | 1 | 2010 | 401 | 0.090 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2009 | 60 | 0.090 |
Why?
| Prospective Studies | 3 | 2016 | 2604 | 0.090 |
Why?
| Societies, Medical | 1 | 2010 | 194 | 0.090 |
Why?
| Stress, Mechanical | 1 | 2009 | 96 | 0.090 |
Why?
| Acid Phosphatase | 1 | 2009 | 15 | 0.090 |
Why?
| Integrases | 3 | 2015 | 45 | 0.090 |
Why?
| Connexin 43 | 1 | 2008 | 23 | 0.080 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2009 | 230 | 0.080 |
Why?
| Receptors, Parathyroid Hormone | 1 | 2008 | 11 | 0.080 |
Why?
| Education, Medical, Continuing | 1 | 2009 | 80 | 0.080 |
Why?
| Multienzyme Complexes | 2 | 2010 | 41 | 0.080 |
Why?
| Inflammation Mediators | 1 | 2009 | 128 | 0.080 |
Why?
| Ovariectomy | 4 | 2013 | 125 | 0.080 |
Why?
| Receptor, Parathyroid Hormone, Type 1 | 1 | 2008 | 24 | 0.080 |
Why?
| Isoenzymes | 1 | 2009 | 177 | 0.080 |
Why?
| Mitosis | 1 | 2008 | 106 | 0.080 |
Why?
| Postmenopause | 1 | 2009 | 102 | 0.080 |
Why?
| Linear Models | 1 | 2009 | 309 | 0.080 |
Why?
| Administration, Oral | 1 | 2009 | 459 | 0.080 |
Why?
| Practice Guidelines as Topic | 1 | 2011 | 492 | 0.080 |
Why?
| Retrograde Obturation | 1 | 2007 | 1 | 0.080 |
Why?
| Mutagenesis, Site-Directed | 1 | 2007 | 117 | 0.080 |
Why?
| Membranes, Artificial | 1 | 2007 | 16 | 0.080 |
Why?
| Intercellular Signaling Peptides and Proteins | 2 | 2010 | 122 | 0.080 |
Why?
| Asthma | 1 | 2011 | 293 | 0.080 |
Why?
| Absorbable Implants | 1 | 2007 | 17 | 0.080 |
Why?
| Gonadal Steroid Hormones | 1 | 2007 | 42 | 0.080 |
Why?
| X Chromosome | 1 | 2006 | 13 | 0.070 |
Why?
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2016 | 673 | 0.070 |
Why?
| Quantitative Trait Loci | 1 | 2006 | 51 | 0.070 |
Why?
| Shc Signaling Adaptor Proteins | 3 | 2011 | 27 | 0.070 |
Why?
| Membrane Glycoproteins | 2 | 2005 | 269 | 0.070 |
Why?
| Models, Animal | 2 | 2017 | 255 | 0.070 |
Why?
| Osteoporosis, Postmenopausal | 1 | 2006 | 36 | 0.070 |
Why?
| Weightlessness | 1 | 2006 | 14 | 0.070 |
Why?
| Phosphorylation | 4 | 2010 | 614 | 0.070 |
Why?
| Rheumatology | 1 | 2006 | 6 | 0.070 |
Why?
| Body Weight | 2 | 2010 | 578 | 0.070 |
Why?
| Carrier Proteins | 2 | 2005 | 359 | 0.070 |
Why?
| Follow-Up Studies | 2 | 2013 | 2387 | 0.070 |
Why?
| Collagen | 1 | 2007 | 223 | 0.070 |
Why?
| Adipocytes | 2 | 2004 | 129 | 0.070 |
Why?
| Wound Healing | 1 | 2007 | 228 | 0.070 |
Why?
| Absorptiometry, Photon | 3 | 2016 | 174 | 0.070 |
Why?
| Lipoproteins, LDL | 2 | 2018 | 195 | 0.070 |
Why?
| Phenotype | 3 | 2015 | 820 | 0.070 |
Why?
| Diet, High-Fat | 2 | 2018 | 216 | 0.060 |
Why?
| Dose-Response Relationship, Drug | 1 | 2009 | 1476 | 0.060 |
Why?
| Compressive Strength | 1 | 2004 | 11 | 0.060 |
Why?
| Seminal Vesicles | 1 | 2004 | 12 | 0.060 |
Why?
| Thiazolidinediones | 1 | 2004 | 95 | 0.060 |
Why?
| Tensile Strength | 1 | 2003 | 33 | 0.060 |
Why?
| Femur Neck | 1 | 2003 | 8 | 0.060 |
Why?
| Arachidonate 15-Lipoxygenase | 2 | 2016 | 17 | 0.060 |
Why?
| Arachidonate 12-Lipoxygenase | 2 | 2016 | 17 | 0.060 |
Why?
| Cysteine Endopeptidases | 1 | 2003 | 75 | 0.060 |
Why?
| Pregnancy, Animal | 1 | 2003 | 30 | 0.060 |
Why?
| Diet, Reducing | 1 | 2003 | 40 | 0.060 |
Why?
| Cell Division | 1 | 2004 | 330 | 0.060 |
Why?
| Mice, 129 Strain | 2 | 2013 | 49 | 0.060 |
Why?
| RNA, Messenger | 4 | 2010 | 1202 | 0.050 |
Why?
| Extracellular Matrix Proteins | 2 | 2014 | 75 | 0.050 |
Why?
| Analysis of Variance | 2 | 2014 | 635 | 0.050 |
Why?
| Sex Characteristics | 1 | 2003 | 214 | 0.050 |
Why?
| 5' Untranslated Regions | 1 | 2020 | 33 | 0.050 |
Why?
| Neoplasm Proteins | 1 | 2003 | 359 | 0.050 |
Why?
| Cell Cycle Proteins | 2 | 2013 | 199 | 0.050 |
Why?
| Gene Knock-In Techniques | 2 | 2010 | 30 | 0.050 |
Why?
| Macrophages | 2 | 2016 | 405 | 0.050 |
Why?
| Transcription, Genetic | 3 | 2010 | 418 | 0.050 |
Why?
| Models, Biological | 3 | 2010 | 823 | 0.050 |
Why?
| Bone Marrow | 2 | 2013 | 411 | 0.040 |
Why?
| Proteins | 1 | 2003 | 376 | 0.040 |
Why?
| Membrane Proteins | 1 | 2020 | 389 | 0.040 |
Why?
| Acid Etching, Dental | 1 | 2017 | 1 | 0.040 |
Why?
| Dental Alloys | 1 | 2017 | 3 | 0.040 |
Why?
| Implants, Experimental | 1 | 2017 | 6 | 0.040 |
Why?
| Dental Prosthesis Design | 1 | 2017 | 16 | 0.040 |
Why?
| Microscopy, Electron, Scanning | 1 | 2017 | 52 | 0.040 |
Why?
| Young Adult | 2 | 2020 | 4318 | 0.040 |
Why?
| Surface Properties | 1 | 2017 | 79 | 0.040 |
Why?
| Materials Testing | 1 | 2017 | 62 | 0.040 |
Why?
| Tibia | 1 | 2017 | 117 | 0.040 |
Why?
| Oxidation-Reduction | 1 | 2018 | 382 | 0.040 |
Why?
| Mice, Inbred BALB C | 1 | 2017 | 368 | 0.040 |
Why?
| Antioxidants | 2 | 2010 | 297 | 0.040 |
Why?
| Bone Substitutes | 1 | 2016 | 12 | 0.040 |
Why?
| Ceramics | 1 | 2016 | 10 | 0.040 |
Why?
| Immunomagnetic Separation | 1 | 2016 | 9 | 0.040 |
Why?
| Genotype | 2 | 2008 | 599 | 0.030 |
Why?
| Swine | 1 | 2017 | 431 | 0.030 |
Why?
| Interleukin-1beta | 1 | 2016 | 92 | 0.030 |
Why?
| Monocytes | 1 | 2016 | 156 | 0.030 |
Why?
| Cell Lineage | 1 | 2015 | 93 | 0.030 |
Why?
| Immunoblotting | 1 | 2015 | 134 | 0.030 |
Why?
| Receptor Activator of Nuclear Factor-kappa B | 2 | 2005 | 32 | 0.030 |
Why?
| Time Factors | 3 | 2008 | 3213 | 0.030 |
Why?
| Hyperthyroidism | 1 | 2014 | 27 | 0.030 |
Why?
| DNA Primers | 1 | 2014 | 225 | 0.030 |
Why?
| Mutation | 1 | 2020 | 1501 | 0.030 |
Why?
| Fractures, Stress | 1 | 2013 | 10 | 0.030 |
Why?
| Gene Knockout Techniques | 1 | 2013 | 45 | 0.030 |
Why?
| Real-Time Polymerase Chain Reaction | 1 | 2014 | 206 | 0.030 |
Why?
| Periodontium | 1 | 2013 | 2 | 0.030 |
Why?
| Alveolar Ridge Augmentation | 1 | 2013 | 5 | 0.030 |
Why?
| Alveolar Process | 1 | 2013 | 14 | 0.030 |
Why?
| Esthetics, Dental | 1 | 2013 | 21 | 0.030 |
Why?
| Adipogenesis | 1 | 2013 | 52 | 0.030 |
Why?
| Alveolar Bone Loss | 1 | 2013 | 15 | 0.030 |
Why?
| Atrophy | 1 | 2013 | 40 | 0.030 |
Why?
| Flow Cytometry | 1 | 2016 | 546 | 0.030 |
Why?
| Mice, Mutant Strains | 1 | 2012 | 84 | 0.030 |
Why?
| Microtubule-Associated Proteins | 1 | 2013 | 78 | 0.030 |
Why?
| Homeostasis | 1 | 2014 | 223 | 0.030 |
Why?
| Uterus | 1 | 2013 | 98 | 0.030 |
Why?
| Histological Techniques | 1 | 2011 | 10 | 0.030 |
Why?
| Infant | 1 | 2020 | 3817 | 0.030 |
Why?
| Adiposity | 1 | 2013 | 142 | 0.030 |
Why?
| MAP Kinase Kinase 4 | 1 | 2011 | 34 | 0.030 |
Why?
| Surgical Flaps | 1 | 2013 | 135 | 0.030 |
Why?
| Chondrocytes | 1 | 2011 | 37 | 0.030 |
Why?
| Image Processing, Computer-Assisted | 1 | 2013 | 256 | 0.030 |
Why?
| Inflammation | 1 | 2016 | 674 | 0.020 |
Why?
| beta Catenin | 1 | 2011 | 102 | 0.020 |
Why?
| Health Planning Guidelines | 1 | 2010 | 13 | 0.020 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 176 | 0.020 |
Why?
| Solubility | 1 | 2010 | 75 | 0.020 |
Why?
| Smad1 Protein | 1 | 2010 | 6 | 0.020 |
Why?
| Genetic Markers | 1 | 2010 | 117 | 0.020 |
Why?
| Glutathione Reductase | 1 | 2010 | 15 | 0.020 |
Why?
| Hip Fractures | 1 | 2010 | 53 | 0.020 |
Why?
| Bone Morphogenetic Proteins | 1 | 2010 | 64 | 0.020 |
Why?
| Chimera | 1 | 2010 | 13 | 0.020 |
Why?
| Glycoproteins | 1 | 2010 | 132 | 0.020 |
Why?
| Bone Morphogenetic Protein 2 | 1 | 2010 | 51 | 0.020 |
Why?
| Transgenes | 1 | 2010 | 55 | 0.020 |
Why?
| Gene Targeting | 1 | 2010 | 32 | 0.020 |
Why?
| Polymerase Chain Reaction | 1 | 2011 | 531 | 0.020 |
Why?
| Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 101 | 0.020 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2010 | 208 | 0.020 |
Why?
| Organ Specificity | 1 | 2010 | 126 | 0.020 |
Why?
| Enzyme Activation | 1 | 2010 | 329 | 0.020 |
Why?
| Diagnostic Imaging | 1 | 2010 | 184 | 0.020 |
Why?
| Thymidine Kinase | 1 | 2008 | 20 | 0.020 |
Why?
| Bone Marrow Cells | 1 | 2010 | 233 | 0.020 |
Why?
| Ganciclovir | 1 | 2008 | 35 | 0.020 |
Why?
| Osteocalcin | 1 | 2008 | 46 | 0.020 |
Why?
| Gene Silencing | 1 | 2008 | 129 | 0.020 |
Why?
| Cohort Studies | 1 | 2013 | 1543 | 0.020 |
Why?
| Collagen Type I | 1 | 2008 | 97 | 0.020 |
Why?
| Child | 1 | 2020 | 7341 | 0.020 |
Why?
| Up-Regulation | 1 | 2010 | 508 | 0.020 |
Why?
| Lymphoid Tissue | 1 | 2007 | 23 | 0.020 |
Why?
| Phosphoproteins | 1 | 2008 | 116 | 0.020 |
Why?
| DNA Replication | 1 | 2008 | 152 | 0.020 |
Why?
| Hormones | 1 | 2007 | 59 | 0.020 |
Why?
| Weight Gain | 1 | 2008 | 243 | 0.020 |
Why?
| Species Specificity | 1 | 2006 | 205 | 0.020 |
Why?
| Promoter Regions, Genetic | 1 | 2008 | 520 | 0.020 |
Why?
| Histocytochemistry | 1 | 2005 | 46 | 0.020 |
Why?
| Blotting, Northern | 1 | 2005 | 108 | 0.020 |
Why?
| Densitometry | 1 | 2004 | 17 | 0.020 |
Why?
| Mesoderm | 1 | 2004 | 33 | 0.020 |
Why?
| Ligands | 1 | 2004 | 230 | 0.020 |
Why?
| PPAR gamma | 1 | 2004 | 79 | 0.020 |
Why?
| Sex Factors | 1 | 2006 | 767 | 0.020 |
Why?
| bcl-Associated Death Protein | 1 | 2003 | 13 | 0.010 |
Why?
| Dactinomycin | 1 | 2003 | 23 | 0.010 |
Why?
| Culture Media, Conditioned | 1 | 2003 | 52 | 0.010 |
Why?
| Fatty Acids | 1 | 2004 | 174 | 0.010 |
Why?
| Core Binding Factor Alpha 1 Subunit | 1 | 2003 | 48 | 0.010 |
Why?
| Cyclic AMP Response Element-Binding Protein | 1 | 2003 | 34 | 0.010 |
Why?
| Polymorphism, Single Nucleotide | 1 | 2006 | 552 | 0.010 |
Why?
| Cyclic AMP-Dependent Protein Kinases | 1 | 2003 | 56 | 0.010 |
Why?
| Genetic Predisposition to Disease | 1 | 2006 | 570 | 0.010 |
Why?
| Rats, Long-Evans | 1 | 2003 | 29 | 0.010 |
Why?
| Hypoglycemic Agents | 1 | 2004 | 177 | 0.010 |
Why?
| Age Factors | 1 | 2006 | 1198 | 0.010 |
Why?
| Iodine Radioisotopes | 1 | 2003 | 43 | 0.010 |
Why?
| Models, Genetic | 1 | 2003 | 209 | 0.010 |
Why?
| HeLa Cells | 1 | 2003 | 291 | 0.010 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2003 | 131 | 0.010 |
Why?
| Mice, Inbred Strains | 1 | 2003 | 198 | 0.010 |
Why?
| Gene Expression | 1 | 2005 | 664 | 0.010 |
Why?
| Adiponectin | 1 | 2003 | 76 | 0.010 |
Why?
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 158 | 0.010 |
Why?
| RNA | 1 | 2003 | 202 | 0.010 |
Why?
| Kinetics | 1 | 2003 | 692 | 0.010 |
Why?
| Adolescent | 1 | 2013 | 6897 | 0.010 |
Why?
| Rats | 1 | 2003 | 3415 | 0.010 |
Why?
| Pregnancy | 1 | 2003 | 2620 | 0.010 |
Why?
|
|
Weinstein's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|